Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. Between 1986 and 1992, 1,024 women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback